Home > Boards > US Listed > Biotechs > Neuronetics Inc. (STIM)

Neuronetics, Inc. is commercial-stage medical technology company. The

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
crudeoil24 Member Profile
Member Level 
Followed By 687
Posts 46,210
Boards Moderated 6
Alias Born 12/12/04
160x600 placeholder
Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting GlobeNewswire Inc. - 6/9/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2021 6:27:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2021 7:16:22 PM
Neuronetics to Present at The JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/3/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:30:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:29:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:28:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:28:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:28:16 PM
Neuronetics Names Todd Cushman as Vice President, Business Development GlobeNewswire Inc. - 6/1/2021 8:00:00 AM
Neuronetics to Present at the William Blair 41st Annual Growth Stock Conference GlobeNewswire Inc. - 5/20/2021 8:00:00 AM
Neuronetics marks 100K NeuroStar treatments at Southern California TMS Center Seeking Alpha - 5/17/2021 9:08:45 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/4/2021 4:35:49 PM
ARNC, BLRX, BLDP and MAXR among midday movers Seeking Alpha - 5/4/2021 12:40:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2021 7:38:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2021 7:31:30 AM
Neuronetics EPS beats by $0.01, beats on revenue Seeking Alpha - 5/4/2021 7:23:28 AM
Neuronetics Reports First Quarter 2021 Financial and Operating Results GlobeNewswire Inc. - 5/4/2021 7:00:00 AM
Neuronetics Employee Patient Advocates Honor Mental Health Awareness Month by Sharing Personal Depression Experiences GlobeNewswire Inc. - 5/3/2021 8:00:00 AM
Neuronetics To Present Clinical Data at The American Psychiatric Association 2021 Annual Meeting GlobeNewswire Inc. - 4/29/2021 8:00:00 AM
Neuronetics to Report First Quarter 2021 Financial and Operating Results and Host Conference Call GlobeNewswire Inc. - 4/20/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/14/2021 5:20:41 PM
Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors GlobeNewswire Inc. - 4/14/2021 5:15:14 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/14/2021 4:10:47 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/14/2021 4:07:33 PM
crudeoil24 Member Level  Tuesday, 06/23/20 11:29:54 AM
Re: None
Post # of 19 
Neuronetics, Inc. is commercial-stage medical technology company. The Company is focused on the design and development of medical devices to treat psychiatric disorders. The Company’s principal product is NeuroStar Advanced Therapy System. It is a non-invasive treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed magnetic field to induce electrical pulses for stimulating certain areas of the brain associated with mood. The system is used to treat adult patients with major depressive disorders. The Company offers its therapy systems to psychiatrist offices in the United States.

New York Yankees and Duke Basketball
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences